3D Communications Contributes to European Regulatory Organization Publication
The November issue of the TOPRA Regulatory Rapporteur features an article entitled “FDA Advisory Committee Meetings: What they are? Why do they happen? and What do they mean for regulatory professionals?”
The article provides a brief history of the purpose and significance of advisory committee meetings, details how a sponsor can best prepare for these high-stakes events, and discusses how an FDA Advisory Committee Meeting can impact a companies’ development plans.
Virginia Cox, JD, a Senior Consultant with 3D Communications, co-authored the article. Before joining 3D, Virginia was the Associate Commissioner for the Office of External Affairs at the U.S. Food and Drug Administration (FDA). Her FDA experience, along with her role as a Communications Lead on numerous 3D FDA Advisory Committee projects, uniquely qualifies her to provide important perspectives on this topic.
For the full article, click HERE.